A breakthrough in cancer treatment just nine years ago has brought new hope to millions of people whose cancers are resistant to all other therapies. The new treatment, cancer immunotherapy, frees the body's potent immune ...
Sep 15, 2021
0
17
Linking the cost of prescription drugs in the United States to the prices paid in other high-income nations could have reduced American spending for the drugs by at least half in 2020, according to a new RAND Corporation ...
Sep 10, 2021
0
3
Impel NeuroPharma, a Seattle-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration last week for its novel nasal spray that treats migraine headaches.
Sep 9, 2021
1
28
In a world of 7.9 billion people, some 5.57 billion COVID-19 vaccine doses have been administered globally. But those doses have not been distributed equally around the world. There's a vast gulf in vaccine rates between ...
Sep 9, 2021
0
5
Epilepsy is one of the most common chronic neurological diseases, affecting more than 50 million people worldwide. Although it is believed that a large proportion of childhood-onset epilepsies are caused by genetic changes, ...
Aug 31, 2021
0
296
Drug delivery plays an important role in the treatment of diseases. Matching a specific drug molecule with the right delivery route optimizes therapeutic performance and minimizes side effects. Associate Professor Matthias ...
Aug 19, 2021
0
0
UK policymakers preparing trade deals post-Brexit can learn important lessons from New Zealand's 'unique drug agency' the Pharmaceutical Management Agency (PHARMAC), if prices for therapies and access to key drugs are to ...
Jul 19, 2021
0
1
Juul, the leading e-cigarette maker in the United States, has agreed to pay $40 million to settle a lawsuit by North Carolina that alleged the company intentionally got scores of teenagers hooked on nicotine.
Jun 28, 2021
0
3
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for ...
Jun 15, 2021
0
4
